conference logo
 
Programme  Titles  Presenters  Topics 
Title Index
18F-FDG PET used in the assessment of meningioma grade
Lingyang Hua1, Ye Gong1, Qing Xie*1, Fengchun Hua2, Hailiang Tang1, Hongda Zhu1, Xiancheng Chen1, Liangfu Zhou1
1the department of Neurosurgery ,Huashan Hospital,Fudan University, China, 2the department of Radiology ,Huashan Hospital,Fudan University, China
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
11:05am
A comprehensive study on malignant meningioma, as WHO Grade III, at Shanghai Huashan Hospital from 2003 to 2008
Ye Gong1,2, Qing Xie*1,2, Hongda Zhu1,2, Hailiang Tang1,2, Lingyang Hua1,2, Xiancheng Chen1,2, Liangfu Zhou1,2
1Huashan Hospital, China, 2Fudan University, China
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
4:30pm
A lack of consent to donate brain tumour tissue for research hampers progress
Helen Bulbeck*1, Neil Bailey2, Kirsten Hopkins3, Clare Mitchell2, Stephen Price4, Willie Stewart6, Kathreena Kurian7, James Nicoll2
1brainstrust: the brain cancer people, UK, 2Clinical Neurosciences, Clinical & Experimental Sciences, University of Southampton, UK, 3Bristol Haematology and Oncology Centre, University Hospitals Bristol, UK, 4Department of Clinical Neurosciences, Addenbrookes Hospital, UK, 5Department of Neuropathology, Southern General Hospital, UK, 6Neuropathology, Derriford Hospital, UK, 7Department of Neuropathology, UK
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
A patient with a secretory meningioma with a KLF4 mutation a novel TRAF7 mutation: Case report and characterization of functional consequences of TRAF7 mutations
Akash Patel*, Tiemo Klisch, Jean-Pierre Revelli, Huda Zoghbi
Baylor College of Medicine, USA
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
8:30am
A single arm, open-label phase II study of Nivolumab in adult participants with recurrent high-grade meningioma
Ian Dunn*1, Sandro Santagata1, Rameen Beroukhim1, Lakshmi Nayak1, Eudocia Quant-Lee1, Andrew Norden1, Mikael Rinne1, Priscilla Brastianos2, Sarah Gaffey1, Patrick Wen1, David Reardon1
1Dana-Farber/Brigham and Women's Hospital, USA, 2Massachusetts General Hospital, USA
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
1:40pm
Anti-tumor activity of CDK 4/6 inhibitor palbociclib in Rb+ meningioma: Pre-clinical assessment
Abhay K Varma*1, David Cachia1, Daniel G McDonald2, Vikram N Samant1, William A Vandergrift III1, Scott M Lindhorst1, Kenneth N Vanek2, Naren L Banik1,5, Joseph M Jenerette III2, Pierre Giglio3, Jeffrey J Raizer4, Sunil J. Patel1, Arabinda Das1
1Department of Neurosurgery and MUSC Brain & Spine Tumor Program, Medical University of South Carolina, USA, 2Department of Radiation Oncology, Medical University of South Carolina, USA, 3Department of Neurological Surgery, Ohio State University, USA, 4Department of Neurology, Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, USA, 5Ralph H Johnson VA Medical Center, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
8:45am
Association of cutaneous meningiomas with resection of prior intracranial meningiomas
Bryan Iorgulescu1,2, Allison Dobry*2, Sandro Santagata1,2, Rebecca Folkerth1,2, Ennio Chiocca1,2, Timothy Smith1,2
1Brigham and Women's Hospital, USA, 2Havard Medical School, USA
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
4:40pm
Can we predict early tumour recurrence in atypical meningioma?
Christopher Millward*2, Karol Budohoski4, James Clerkin3, Chris Barton5, Samantha Mills2, Michael Farrell3, Seamus Looby3, Thomas Santarius4, Mohsen Javadpour3, Ramez Kirollos4, Michael Jenkinson1,2
1University of Liverpool, UK, 2The Walton Centre NHS Foundation Trust, UK, 3Beaumont Hospital, Ireland, 4Addenbrookes Hospital, UK, 5Alder Hey Hospital, UK
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
11:20am
Challenges in the design of clinical trials investigating targeted therapy in meningiomas
Mariza Daras, Ingo Mellinghoff, Thomas Kaley*
Memorial Sloan Kettering Cancer Center, USA
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
2:10pm
Clinical impact of targeted amplicon sequence for meningioma as a practical clinical sequence system
Hiroshi Nishihara*1,2, Sayaka Yuzawa1, Shigeru Yamaguchi1, Hiromi Mohri1,3, Lei Wang1, Taichi Kimura1,2, Masumi Tsuda1, Mishie Tanino1, Hiroyuki Kobayashi1, Shunsuke Terasaka1, Kiyohiro Houkin2, Shinya Tanaka1
1Hokkaido University, Graduate School of Medicine, Japan, 2Hokkaido University Hospital, Japan, 3Hokuto Hospital, Japan
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
8:45am
Clinical next-generation sequencing in meningiomas
Katherine Schwetye*, Jamal Carter, Christina Tsien, Robert Schmidt, Albert Kim, Sonika Dahiya
Washington University School of Medicine, USA
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
9:45am
Clinical trial of autologous tumor lysate vaccines after surgical resection for the treatment of meningioma in dogs
G. Elizabeth Pluhar*, Matthew A. Hunt, Micheal R. Olin
University of Minnesota, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
8:30am
Clonal selection toward TERT promoter mutations in progressive recurrent meningiomas
Tareq A Juratli*1, Matthias Kirsch1, Christian Thiede2, Dirk Daubner3, Dietmar Krex1,5, Mechthild Krause4,6, Priscilla BrastianoS7, Daniell P Cahill8, Gabrielle Schackert1,5
1Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, 2Division of Hematology, Oncology and Stem Cell Transplantation, Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, 3Department of Neuroradiology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, 4Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology, Germany, 5German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ), Germany, 6Department of Radiation Oncology and OncoRay, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany, 7Department of Medicine, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, USA, 8Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, USA
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
8:15am
Combined multimodality treatment with hypoxia-activated prodrug TH-302 and XRT results in enhanced antitumor efficacy in preclinical malignant meningioma mouse model
Asif Maknojia*, Michael Garcia, David Cavazos, Courtney Bosse, Aleksandra Gruslova, Nikos Papanikolaou, Andrew Brenner, John Floyd
University of Texas Health Science Center at San Antonio, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
9:10am
Comparative genomics: the dog as a translational model for meningioma
M. R. Chambers*1, Daxa M. Patel1, Kimberly P. Kicielinski1, Frank Crisona1, Dongquan Chen1, Trenton R. Schoeb1, Andy Shores3, Donald Sorjonen2, Calvin M. Johnson2, David K. Crossman1, G. Yancey Gillespie1
1University of Alabama at Birmingham, USA, 2Auburn University College of Veterinary Medicine, USA, 3Mississippi State University College of Veterinary Medicine, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
9:00am
Comparison of ABC/2 estimation method with computerized volumetric growth rate analysis in meningiomas
Charles Opalak, Matthew Parry, Aravind Somasundaram, Serendipity Rinonos, Vyshak Chandra*, Emmy Miller, Adam Sima, Kathryn Workman, Sharon Wolber, William Broaddus
Virginia Commonwealth University, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Concept for EANO guidelines for the diagnosis and treatment of meningiomas
Roland Goldbrunner*1, Giuseppe Minniti2, Matthias Preusser3, Michael D. Jenkinson4, Kita Sallabanda5, Emmanuel Houdart6, Andreas von Deimling7, Pantelis Stavrinou1, Florence Lefranc8, Morten Lund-Johansen9, Elizabeth Cohen-Jonathan Moyal10, Dieta Brandsma11, Roger Henriksson12, Riccardo Soffietti13, Michael Weller14
1Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Germany, 2Radiation Oncology Unit, Sant’Andrea Hospital, University of Rome Sapienza, Roma, and IRCCS Neuromed, Italy, 3Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria, 4Department of Neurosurgery, University of Liverpool and The Walton Centre, UK, 5Department of Neurosurgery, University Hospital San Carlos, Universidad Cumplutense and IMOncology Madrid Arturo Soria, Area de Oncologia Radioterapica Robotizada – Cyberknife, Spain, 6Service de Neuroradiologie, Hôpital Lariboisière, France, 7Department of Neuropathology, Institute of Pathology, University of Heidelberg, and, CCU Neuropathology German Cancer Center (DKFZ), Germany, 8Department of Neurosurgery, Hôpital Erasme, Université Libre de Bruxelles, Belgium, 9Department of Neurosurgery, Bergen University Hospital and Department of Clinical Medicine, Faculty of Medicine and Dentistry, University of Bergen, Norway, 10Department of Radiation Oncology, Institut Universitaire du Cancer de Toulouse Oncopole, France, 11Department of Neur-Oncology, Netherlands Cancer Institute – Antoni van Leeuwenhoek, The Netherlands, 12Regional Cancer Centre Stockholm, and Department of Radiation Science & Oncology, University of Umea, Sweden, 13Department of Neuro-Oncology, University and City of Health and Science Hospital, Italy, 14Department of Neurology, University Hospital & University of Zurich, Switzerland
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
11:25am
Degree of vascular encasement in sphenoid wing meningiomas predicts postoperative ischemic complications
D. Jay McCracken*, Raymond Higginbotham, Jason Boulter, John Wells, Sameer Halani, Yuan Liu, Amit Saindane, Jeffrey Olson
Emory University, USA
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
1:45pm
Development of clinical precision medicine approaches in meningiomas
Priscilla Brastianos*1, Qian Shi2, Sandro Santagata3, Keith Anderson2, Suriya Jeyapalan4, Dan Cahill1, Elise Horvath5, Fred Barker1, Evanthia Galanis6
1Massachusetts General Hospital Cancer Center, USA, 2Alliance Statistics and Data Center, Mayo Clinic, USA, 3Brigham and Women's Hospital, Harvard Medical School, USA, 4Tufts University, USA, 5Alliance Protocol Operations Office, USA, 6Mayo Clinic, -
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
1:30pm
Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of NF Mutation status in meningioma
Abhay K Varma*1, David Cachia1, Vikram N. Samant1, Michele Decandio1, William A. Vandergrift III1, Scott M. Lindhorst1, Naren L. Banik1, Pierre Giglio2, Jeffrey J Raizer3, Sunil J. Patel1, Arabinda Das1
1Department of Neurosurgery and MUSC Brain & Spine Tumor Program, Medical University of South Carolina, USA, 2Department of Neurological Surgery, Ohio State University Wexner Medical College, USA, 3Department of Neurology and Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
9:30am
Endonasal endoscopic transsphenoidal excision of tuberculum sellae meningiomas - A systematic review
Mazda K. Turel*, Georgios Tsermoulas, Deven Reddy, Hugo Andrade-Barazarte, Gelareh Zadeh, Fred Gentili
Division of Neurosurgery, Toronto Western Hospital, Canada
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
4:00pm
Epigenetic profiling and mathematical modeling reveals CpG hypermethylation phenotypes associated with recurrence-free survival in meningioma
Adriana Olar*1, Khalida M. Wani2, Charmaine D. Wilson3, Gelareh Zadeh4, Franco DeMonte5, David Jones6, Stefan Pfister6, Andreas von Deimling6, Erik P. Sulman2,7, Kenneth D. Aldape8
1MD Anderson Cancer Center, Hematopathology, USA, 2MD Anderson Cancer Center, Translational Molecular Pathology, USA, 3UT School of Nursing, Center for Nursing Research, USA, 4University of Toronto, Neurosurgery, Canada, 5MD Anderson Cancer Center, USA, 6German Cancer Research Center, Germany, 7MD Anderson Cancer Center, Radiation Oncology, USA, 8MacFeeters-Hamilton Brain Tumor Center and Princess Margaret Cancer Center, Canada
Saturday, June 18, 2016:  SESSION 6 (continued): Genomics and Molecular Advances in Meningioma  -  10:10am - 11:10am
Epigenomic landscape of adult gliomas, a bioinformatics journey
Houtan Noushmehr
University of Sao Paulo, Ribeirao Preto Medical School, Brazil
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Evaluation of meningioma margin is a superior predictor of surgical plane than the classical CSF-cleft
Rajeev Sen*, Leah Katz, Girish Fatterpekar, Josh Silverman, Benjamin Liechty, Matija Snuderl, John Golfinos, Donato Pacione, Chandra Sen
NYU Langone Medical Center, USA
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
11:50am
Evaluation of perioperative radiologic characteristics as predictors of intracranial meningioma recurrence following surgical resection
George Klironomos, Lior Gonen, Alireza Mansouri*, Alexandra Kilian, Fred Gentili, Gelareh Zadeh
University Of Toronto, Canada
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
11:10am
Exploring microstructure of meningioma using Neurite Orientation Dispersion and Density Imaging
Shin Tai Chong1, Nai-Wei Yao2, Chun-Yi Lo1, Hong-Wen Gao3, Chiao-Chi Chen2, Ching-Po Lin1, Chen Chang*2
1Institute of Neuroscience, National Yang-Ming University, Taiwan, 2Institute of Biomedical Sciences, Academia Sinica, Taiwan, 3Department of Radiology, Tri-Service General Hospital, Taiwan
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Expression analysis of anti-apoptotic genes in lower grade meningiomas
Indira Franco, Sarah Bomfim, Paulo Novais, Andressa Rodrigues, Marcella Rosa*, Marina Azzem, Vagner Sarraipo, Luciano Neder, Daniela Tirapelli, Benedicto Colli, Carlos Carlotti, Luis Tirapelli
Ribeirao Preto Medical School, University of São Paulo, Brazil
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Genetic characterization demonstrates high frequency of clinically actionable mutations in SMO and AKT1 in skull base meningiomas
Priscilla Brastianos*1, Matthew Strickland1, Corey Gill1, Naema Nayyar1, Megan D'Andrea1, Darrell Borger1, Sandro Santagata2, Matthew Frosch1, Daniel Cahill1, Frederick Barker1
1Massachusetts General Hospital, USA, 2Brigham and Women's Hospital, USA
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
9:25am
Global loss of histone H3K27 trimethylation in atypical and anaplastic meningiomas
Leah Katz*, Rajeev Sen, Girish Fatterpekar, Joshua Silverman, John Golfinos, Chandra Sen, David Zagzag, Matija Snuderl
NYU Langone Medical Center, USA
Saturday, June 18, 2016:  SESSION 6 (continued): Genomics and Molecular Advances in Meningioma  -  10:10am - 11:10am
10:20am
Growth patterns of meningiomas during observation
Charles Opalak, Serendipity Rinonos, Aravind Somasundaram, Vyshak Chandra*, Matthew Parry, Emmy Miller, Adam Sima, Kathryn Workman, Sharon Wolber, William Broaddus
Virginia Commonwealth University, USA
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
11:35am
Health-related quality of life in meningioma patients – a systematic review
Amir H. Zamanipoor Najafabadi*1, Marthe C.M. Peeters1, Linda Dirven1, Marike L.D. Broekman2, Wilco C. Peul1, Martin J.B. Taphoorn1, Wouter R. van Furth1
1Leiden University Medical Center, The Netherlands, 2University Medical Center Utrecht, The Netherlands
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
3:40pm
High Ki67 labeling index in resected WHO grade 1 meningiomas correlates with a higher rate of recurrence
Kamila Nowak*, James Casey, Ameet Chitale, Ingrid Kalchman, Elizabeth Buss, Scott Keith, Sarah Hegarty, Mark Curtis, Charalambos Solomides, Wenyin Shi, Kevin Judy, David Andrews, Christopher Farrell, Maria Werner-Wasik
Sidney Kimmel Medical College at Thomas Jefferson University, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Histopathological prognostic factors of recurrence following surgery and radiation therapy for atypical and malignant meningiomas
Daniel Kim, Andrzej Niemierko, William L. Hwang, Anat O. Stemmer-Rachamimov, William T. Curry, Fred G. Barker, II, Robert L. Martuza, Kevin S. Oh, Jay S. Loeffler, Helen A. Shih*
Massachusetts General Hospital, Radiation Oncology, USA
Saturday, June 18, 2016:  SESSION 6 (continued): Genomics and Molecular Advances in Meningioma  -  10:10am - 11:10am
10:10am
Incidental meningioma management - a survey clinical practice of UK neurosurgeons
Michael Jenkinson*1,2, Mujtaba Mohammad1, Rasheed Zakaria1,2, Emmanuel Chavredakis2, Andrew Brodbelt2
1University of Liverpool, UK, 2The Walton Centre NHS Foundation Trust, UK
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
3:30pm
Increased risk of meningiomas in male-to-female transgender subjects using estrogens/progestogens
Paula Valerie Ter Wengel*, Enrico Martin, Martin Den Heijer, Louis Gooren, Saskia Peerdeman
VUMC, The Netherlands
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Intermediate-risk meningioma: Initial outcomes from NRG Oncology/RTOG-0539
Leland Rogers*1, Peixin Zhang2, Michael Vogelbaum3, Arie Perry4, Lynn Ashby5, Jignesh Modi6, Anthony Alleman7, James Galvin8, David Brachman5, Joseph Jenrette9, John de Groot10, Joseph Bovi11, Maria Werner-Wasik12, Jonathan Knisely13, Minesh Mehta14
1Virginia Commonwealth University, USA, 2NRG Oncology, USA, 3Cleveland Clinic, USA, 4University of California, San Francisco, USA, 5Barrow Neurological Institute, USA, 6Yale University, USA, 7University of Oklahoma, USA, 8IROC Philadelphia RT, USA, 9Medical University of South Carolina, USA, 10MD Anderson Cancer Center, USA, 11Medical College of Wisconsin, USA, 12Thomas Jefferson University, USA, 13Hofstra North Shore-LIJ School of Medicine,, USA, 14University of Maryland, USA
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
1:15pm
Intraoperative consistency of intracranial meningiomas influences the extent of surgical resection
JW Lucas, G Zada*
University of Southern California, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Intraoperative CT (iCT) for surgery of meningiomas of the anterior skull base
N. Terpolili, W. Rachinger, C. Schnichor, J-C Tonn*
Dept of Neurosurgery LMU, Germany
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
11:15am
Landscape of genomic alterations in high-grade meningiomas
Wenya Linda Bi1,3, Malak Abedalthagafi2, Noah Greenwald1,3, Pankaj Agarwalla3, Peleg Horowitz1,3, Will Gibson3,4, Ossama Al-Mefty1, Sandro Santagata2, Rameen Beroukhim3,4, Ian Dunn*1
1Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, USA, 2Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, USA, 3Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, USA, 4Broad Institute of MIT and Harvard, USA
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
9:00am
Long-term outcome and prognostic factors in non-benign meningiomas
Annamaria Biczok1, Kraus Theo2, Niklas Thon1, Jörg-Christian Tonn*1, Christian Schichor1
1Department of Neurosurgery, Ludwig-Maximilians University, Germany, 2Department of Neuropathology, Ludwig-Maximilians University, Germany
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
3:05pm
Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of4565 patients
Antonio Santacroce1,2
1Department Neurosurgery Universitätsklinikum Tübingen Eberhard Karls-Universität Tübingen, Germany, 2Department of Neurosugery Medical Faculty Heinrich Heine University Düsseldorf, Germany, 3Gamma Knife Zentrum Krefeld, Germany
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
2:45pm
Medical therapy for atypical and anaplastic meningioma
Nehaw Sarmey, Suresh Kumar Balasubramanian, Manmeet Ahluwalia*
Cleveland Clinic, USA
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
11:40am
Meningeal hemangiopericytomas: Imaging features helpful in distinguishing these tumors from meningiomas
Zehra Hooda*1,2, John A. Arrington2, Nam D. Tran2, Solmaz Sahebjam2
1Department of Neurology, University of South Florida, USA, 2H. Lee Moffitt Cancer Center & Research Institute, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
microRNA-181d as biomarker in meningiomas progression
Vinicius Carneiro, Andressa Rodrigues*, Marcella Rosa, Luciano Neder, Daniela Tirapelli, Benedicto Colli, Carlos Carlotti
Ribeirao Preto Medical School, University of São Paulo, Brazil
Saturday, June 18, 2016:  SESSION 6 (continued): Genomics and Molecular Advances in Meningioma  -  10:10am - 11:10am
10:30am
Molecular classification of meningiomas across all histological subtypes and grades
Felix Sahm*1,2, David TW Jones3, Daniel Schrimpf1, David Reuss1,2, David Capper1,2, Christian Kölsche1,2, Christian Mawrin4, Marcel Seiz5, Werner Paulus6, Stefan M Pfister3,7, Christel Herold-Mende8, Andreas von Deimling1
1Dept. of Neuropathology, Germany, 2CCU Neuropathology DKFZ, Germany, 3Div. of Pediatric Neurooncology DKFZ, Germany, 4Dept. of Neuropathology, Germany, 5Dept. of Neurosurgery, Germany, 6Institute of Neuropathology, Germany, 7Dept. Pediatric Oncology, Germany, 8Dept. of Neurosurgery, Germany
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
8:00am
Mouse models of meningioma tumorigenesis
M Kalamarides*1,3, J Boetto3, F Bielle2,3, M Peyre1,3
1Department of Neurosurgery, Hopital Pitie-Salpetriere, France, 2Department of Neuropathology, Hopital Pitie-Salpetriere, France, 3Inserm U1127, Institut Cerveau et Moelle Epiniere, France, 4Sorbonne University, France
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
8:15am
Near infrared optical contrast agent for improved margin detection during meningioma surgery
John Lee*, John Pierce, Ryan Zeh, Ollin Venegas, Sarah Nims, Kim Learned, Jayesh Thawani, Maria Martinez-Lage, Sunil Singhal
University of Pennsylvania, USA
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
10:45am
Outcome analysis of malignant meningoma patients from a single institution
Suresh kumar Balasubramanian, Mayur Sharma, Danilo Silva, Glen Stevens*, Erin Murphy, John Suh, Paul Elson, Samuel Chao
Cleveland Clinic Foundation, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Patient-derived orthotopic malignant meningioma models for targeted virus therapy development
Fares Nigim, Shin-ichi Esaki, Michael Hood, Nina Lelic, Marianne James, Vijaya Ramesh, Anat Stemmer-Rachamimov, Daniel Cahill, Priscilla Brastianos, Samuel Rabkin, Robert Martuza, Hiroaki Wakimoto*
Massachusetts General Hospital, Harvard Medical School, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
9:40am
Patient-reported outcome measures in meningioma research – lack of the patients perspective
Amir H. Zamanipoor Najafabadi*1, Linda Dirven1, Marike L.D. Broekman2, Wilco C. Peul1, Martin J.B. Taphoorn1, Wouter R. van Furth1
1Leiden University Medical Center, The Netherlands, 2University Medical Center Utrecht, The Netherlands
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the SEER database
Sarah Randall2, Michelle Torok2, Michael Handler2, Nicholas Foreman2, Arthur Liu2, Todd Hankinson2, Roy Dudley*1
1Montreal Children's Hospital, McGill University Health Centres, Canada, 2Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, USA
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
1:55pm
Post-operative hematoma size in atypical vs. typical meningiomas
Omid Shearkhani*, Arjun Sahgal, Todd Mainprize, Farhad Pirouzmand, Pejman Jabehdar Maralani
University of Toronto, Canada
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Postradiotherapy peritumoral symptomatic edema after radiation therapy for intracranial meningiomas: patterns and predictive factors
Naoual Oulmoudne, Robert Moumdjian, Laura Masucci, Roberge David, Cynthia Menard, Michel Bojanowski, Alain Bouthillier, Françoise Berthelet, François Guilbert, Jean Paul Bahary*
Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, Canada
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Potential therapeutic role of transcranial magnetic resonance-guided focused ultrasound surgery in recurrent skull base meningioma, a feasibility study
FARHAD PIROUZMAND*1,2, NIR LIPSMAN1,2, Kullervo Hynynen1,2, SUGANTH SUPPIAH1,2
1Sunnybrook Hospital, Canada, 2university of Toronto, Canada
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
11:30am
Prediction and impact of meningioma consistency for surgical outcome
Raphael Schwarz*1, Till Burkhardt1, Jan Sedlacik2, Eik Vettorazzi3, Manfred Westphal1, Nils Ole Schmidt1
1University Medical Center Hamburg-Eppendorf-Neurosurgery, Germany, 2University Medical Center Hamburg-Eppendorf-Neuroradiology, Germany, 3University Medical Center Hamburg-Eppendorf-Biometrics, Germany
Saturday, June 18, 2016:  SESSION 7: Lessons from Our Clinical Experience in Meningioma  -  11:10am - 12:10pm
12:00pm
Prognostic factors for local recurrence in atypical meningioma
S SHAKIR*1, L Souhami1, K Petrecca2, J Mansure3, S Khushdeep1, V Panet-Raymond1, G Shenouda1, A Al Odaini4, M Brown1, B Abdulkarim1, MC Guiot4
1McGill University Health Center, Departments of Radiation Oncology, Canada, 2McGill University Health Center, Departments of Neurosurgery, Canada, 3McGill University Health Center, Departments of Oncology Research, Canada, 4McGill University Health Center, Departments of Neuropathology, Canada
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
1:30pm
Prognostic value of radiomics  in meningioma recurrence
Thibaud Coroller*1, Wenya Linda Bi1, Malak Abedalthagafi1,2, Ayal Aizer1, Winona Wu1, Noah Greenwald1, Rameen Beroukhim1, Ossama Al-Mefty1, Sandro Santagata1, Ian Dunn1, Brian Alexander1, Raymond Huang1, Hugo Aerts1
1Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, USA, 2King Fahad Medical City, King Abdulaziz City for Science and Technology, Saudi Arabia
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
10:55am
Prospective trial of surgery and permanent intraoperative brachytherapy (S+BT) using a modular, biocompatable radiation implant for recurrent aggressive meningiomas
David Brachman*1,2, Christopher Dardis1,3, Peter Nakaji1,2, Emad Youssef1,2, Theresa Thomas3,2, Kris Smith1, Nader Sanai1, Stephen Sorensen3
1Barrow Neurological Institute, USA, 2GammaTile, LLC, USA, 3St Josephs Hospital/Dignity Health, USA
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
2:00pm
Purely intraosseous benign meningioma of the skull: outcomes of maximal resection in 9 patients
Bryan Iorgulescu*1,2, Joe Tung2, Sandro Santagata1,2, Rory Crotty2,3, Rebecca Folkerth1,2, Ossama Al-Mefty1,2, Timothy Smith1,2
1Brigham and Women's Hospital, USA, 2Harvard Medical School, USA, 3Massachusetts General Hospital, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Radiosensitization of malignant meningioma cells with LB100, a protein phosphatase 2A inhibitor
Saman Sizdahkhani1, Winson S. Ho*1, Anita Tandle2, Nicole A. Colwell3, Shuyu Hao3, Dragan Maric4, Mones S. Abu-Asab5, Randy L. Jensen6, David L. Gillespie7, Mark R. Gilbert3, Zhengping Zhuang1, Deric M. Park3
1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, USA, 2Radiation Oncology Branch, National Cancer Institute, NIH, USA, 3Neuro-Oncology Branch, National Cancer Institute, NIH, USA, 4NINDS Flow Cytometry Core Facility, National Institute of Neurological Disorders and Stroke, NIH, USA, 5Histopathology Core, National Eye Institute, NIH, USA, 6Department of Neurosurgery, Huntsman Cancer Institute, Department of Radiation Oncology, Department of Oncological Sciences, University of Utah, USA, 7Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, USA
Friday, June 17, 2016:  SESSION 1: Tumor Biology: Animal Modeling and Cell Biology  -  8:15am - 10:30am
9:20am
Radiosurgery for cavernous sinus, petroclival and cerebello pontine angle meningiomas: a comparative analysis
Antonio Santacroce*1,2, Hans Jakob Steiger1,3, Gerhard Horstmann2, Jean Regis4
1Department of Neurosurgery Universitätsklinikum Tübingen Eberhard Karls-Universität Tübingen, Germany, 2Gamma Knife Zentrum Krefeld, Germany, 3Department of Neurosugery Medical Faculty Heinrich Heine University Düsseldorf, Germany, 4Department of stereotactic and functional neurosurgery CHU la TImone, France
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
3:20pm
Radiosurgery for parasagittal meningiomas
Antonio Santacroce*1,2, Hans Jakob Steiger2, Gerhard Horstmann3, Jean Regis4
1Department of Neurosurgery Universitätsklinikum Tübingen Eberhard Karls-Universität Tübingen, Germany, 2Department of Neurosrugery Medical Faculty Heinrich Heine University Düsseldorf, Germany, 3Gamma Knife Zentrum Krefeld, Germany, 4Department of stereotactic and functional neurosurgery CHU la TImone, France
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Resection of ventrally located meningiomas of the craniovertebral junction using an adaptable minimal invasive approach via the posterior atlantooccipital membrane
Nils Ole Schmidt*, Christian Mende, Lasse Dührsen, Manfred Westphal, Sven Eicker
University Medical Center Hamburg-Eppendorf, Germany
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
3:20pm
Response Assessment in Neuro-Oncology (RANO) criteria for meningiomas
Patrick Wen*1, David Schiff2, Thomas Kaley3, Marc Chamberlain4, Raymond Huang1, Leland Rogers5, Michael Mcdermott6, Matthias Preusser7, Michael Weller8, Jorg-Christian Tonn9, David Reardon1, Eva Galanis10, Damien Weber8, Michael Vogelbaum11
1Dana-Farber Cancer Institute, USA, 2University of Virginia, USA, 3Memorial Sloan Kettering Cancer Center, USA, 4University of Washington, USA, 5Virginia Commonwealth Unversity, USA, 6University of California, San Francisco, USA, 7Medival University of Vienna, Austria, 8University of Zurich, Switzerland, 9University of Munich, Germany, 10Mayo Clinic, USA, 11Cleveland Clinic, USA
Friday, June 17, 2016:  SESSION 2: Radiology, Response and RANO in Meningioma  -  10:30am - 12:30pm
10:30am
Response of a meningioma to tumor treating fields (TTFields)
Lauren Schaff1, Jai Grewal2, Barbara Beiss2, Fabio Iwamoto*1
1Columbia University, USA, 2Novocure, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Risk factors and risk model of preoperative and early postoperative seizures in meningioma patients
Marco Skardelly1,6, Christian Rother1,6, Susan Noell1,6, Felix Behling1,6, Thomas V. Wuttke1,2, Jens Schittenhelm3,7, Sotirios Bisdas4,7, Christoph Meisner5, Sabine Rona1, Ghazaleh Tabatabai*1,6, Florian Roser1, Marcos Tatagiba1
1Department of Neurosurgery, University Hospital Tuebingen Eberhard Karls University Tuebingen, Germany, 2Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research Eberhard Karls University Tuebingen, Germany, 3Institute of Pathology and Neuropathology, Division of Neuropathology University Hospital Tuebingen, Eberhard Karls University Tuebingen, Germany, 4Department of Neuroradiology University Hospital Tuebingen, Eberhard Karls University Tuebingen, Germany, 5Institute of Clinical Epidemiology and Applied Biometry University Hospital Tuebingen, Eberhard Karls University Tuebingen, Germany, 6Interdisciplinary Division of Neuro-Oncology Departments of Vascular Neurology and Neurosurgery University Hospital Tuebingen Eberhard Karls University of Tübingen Hertie Institute for Clinical Br, Germany, 7Neuro-Oncology Center Comprehensive Cancer Center Tübingen, University Hospital Tuebingen Eberhard Karls University of Tuebingen, Germany
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
2:05pm
Role of neutrophil-to-lymphocyte ratio as an inflammatory marker associated with malignant behavior in benign and atypical meningioma
Quinn T. Ostrom*, Yanwen Chen, Jill S. Barnholtz-Sloan
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, USA
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Salvage re-irradiation for high-risk meningiomas
Ryan Lanning*, Muhammad Chohan, Christopher Ryan, Ranjodh Singh, Zachary Kohutek, Shahiba Ogilvie, Lajhem Cambridge, Yoshiya Yamada, Vivane Tabar, Thomas Kaley, Kathryn Beal, Philip Gutin
Memorial Sloan Kettering Cancer Center, USA
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
3:00pm
Seizure prophylaxis in meningioma surgery – are we practicing evidence-based medicine?
Michael Jenkinson*1,2, Christopher Barton3, Christopher Millward2, Rasheed Zakaria1,2, Emmanuel Chavredakis2, Andrew Brodbelt2
1University of Liverpool, UK, 2The Walton Centre NHS Foundation Trust, UK, 3Alder Hey Hospital, UK
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
3:50pm
Skull base meningiomas: are surgery and radiotherapy comparable?
Robert Smee*1,2, Janet Williams1
1Department of Radiation Oncology, The Prince of Wales Cancer Centre, Australia, 2UNSW Clinical School, Australia, 3Tamworth Base Hospital, Australia
Saturday, June 18, 2016:  SESSION 9: Radiation Therapy and Radiosurgery Practices for Meningioma  -  2:45pm - 3:50pm
3:10pm
Somatostatin receptor-targeted radionuclide therapy for progressive meningioma
Katharina Seystahl1, Veit Stoecklein2, Ulrich Schüller3, Elisabeth Rushing4, Guillaume Nicolas5, Niklaus Schäfer6, Harun Ilhan7, Athina Pangalu8, Michael Weller1, Jörg-Christian Tonn*2, Michael Sommerauer1,6, Nathalie Jansen7
1Department of Neurology, University Hospital, Switzerland, 2Department of Neurosurgery, University Hospital LMU, Germany, 3Department of Neuropathology University Hospital LMU, Germany, 4Department of Neuropathology, University Hospital, Switzerland, 5Department of Nuclear Medicine, University Hospital, Switzerland, 6Department of Nuclear Medicine, University Hospital, Switzerland, 7Department of Nuclear Medicine, University Hospital LMU, Germany, 8Department of Neuroradiology, University Hospital, Switzerland
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
2:25pm
Stereotactic radiosurgery for large meningiomas: patterns of symptom improvement and complication
Linda W Xu*, Griffith R Harsh, Scott G Soltys, Iris C Gibbs, Steven D Chang
Stanford University Hospital and Clinics, USA
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
2:35pm
Surgical assessment and morphometric comparison of classic cranio-orbitotomy (CO) and modified superolateral (MSL) approach for orbital apex meningioma
FARHAD PIROUZMAND
Sunnybrook Hospital, Canada
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Surgical treatment of large hyperostotic meningiomas: a novel technique for perioperative 3D skull reconstruction
Mirjam van der Mark*1, Rianne van Loenen2, Frank Verver2, Jan Wolff2, Sander Idema1, Saskia Peerdeman1
1VU university medical center, department of Neurosurgery, The Netherlands, 2VU university medical center, 3D InnovationLab, department of Fysics and Medical Technology and department of Oral and Maxillofacial Surgery, The Netherlands
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
4:10pm
The IDEAL framework and neurosurgery: a case study - endoscopic endonasal meningioma surgery
Ivo Muskens1, Sander Diederen1, Amir Zamanipoor Najafabadi2, Wouter van Furth2, Anne May3, Timothy Smith4, Annelien Bredenoord5, Marike Broekman*1
1Dept. of Neurosurgery, University Medical Center Utrecht, The Netherlands, 2Dept. of Neurosurgery, Leiden University Medical Center, The Netherlands, 3Dept. of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands, 4Dept. of Neurosurgery, Brigham and Women’s Hospital, USA, 5Dept. of Medical Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
2:50pm
The impact of race on survival in benign meningioma: A retrospective study from a single brain tumor center
Adam Robin, Aqueel Pabaney, Laila Poisson*, Ian Lee
Henry Ford Hospital, USA
Friday, June 17, 2016:  SESSION 3: Clinical Studies--Guiding Future Care for Meningioma  -  1:30pm - 3:35pm
2:15pm
The relationship of operative length to post-operative complications in meningioma surgery: a NSQIP analysis
Aditya V. Karhade*1, David J. Cote1, Marike L. Broekman2, Linda S. Aglio1, Ian F. Dunn1, Timothy R. Smith1
1Brigham and Women's Hospital, Harvard Medical School, USA, 2University Medical Center, The Netherlands
Friday, June 17, 2016:  SESSION 4: Surgical Perspectives for Meningioma  -  3:50pm - 4:50pm
4:20pm
The ROAM / EORTC 1308 trial: Radiation versus Observation following surgical resection of atypical meningioma: a randomised controlled trial – study update
Michael Jenkinson*1,2, Mohsen Javadpour3, Brian Haylock4, Bridget Young1, Helen Hind1, Jacqui Vinten2, Helen Bulbeck8, Kumar Das2, Michael Farrell3, Seamus Looby3, Helen Hickey1, Matthias Preusser5, Conor Mallucci1, Dyfrig Hughes6, Carroll Gamble1, Damien Weber7
1University of Liverpool, UK, 2The Walton Centre NHS Foundation Trust, UK, 3Beaumont Hospital, Ireland, 4Clatterbridge Cancer Centre, UK, 5Comprehensive Cancer Center, Austria, 6Bangor University, UK, 7Centre for Proton Therapy, Paul Scherrer Institute, Switzerland, 8brainstrust charity, UK
Saturday, June 18, 2016:  SESSION 8: Update on International Clinical Trials in Meningioma  -  1:15pm - 2:45pm
1:50pm
The UK top ten clinical research priority questions in neuro-oncology
Helen Bulbeck*1, Robin Grant2,3, Julia Day3, Laura MacDonald4, Richard Morley5, Kathy Oliver6
1brainstrust: the brain cancer people, UK, 2Department of Clinical Sciences, Western General Hospital, UK, 3NHS Lothian, UK, 4Cochrane Collaboration, UK, 5James Lind Alliance, UK, 6International Brain Tumour Alliance, UK
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade
Christel Herold-Mende*1, Melissa Schmidt1, Andreas Mock1, Christin Jungk1, Felix Sahm2, Katrin Lamszus3, Ralf Ketter4, Almuth Kessler5, Mario Löhr5, Christian Senft6, Manfred Westphal3, Andreas von Deimling2, Andreas Unterberg1, Matthias Simon7
1University of Heidelberg, Dpt. Neurosurgery, Germany, 2Dpt. Neuropathology, CCU Neuropathology, DKTK, DKFZ, Germany, 3Dpt. Neurosurgery, University Medical Center Hamburg-Eppendorf, Germany, 4Dpt. Neurosurgery, Saarland University, Medical School, Germany, 5Dpt. Neurosurgery, University Hospital of Würzburg, Germany, 6Dpt. Neurosurgery, University of Frankfurt, Germany, 7Dpt. Neurosurgery, University Hospital Bonn, Germany
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
9:15am
Transcriptomic analysis of meningiomas with or without deletion of chromosome 22q
Irineu Renzi, Marina Silveira, Andressa Rodrigues*, Marcella Rosa, Luciano Neder, Benedicto Colli, Daniela Tirapelli, Carlos Carlotti
Ribeirão Preto Medical School, University of São Paulo, Brazil
Saturday, June 18, 2016:  SESSION 6: Genomics and Molecular Advances in Meningioma  -  8:00am - 9:55am
9:35am
Value based healthcare framework for hyperostotic sphenoid wing meningioma patients
Wouter van Furth*, Amir Zamanipoor, Stijn Genders
LUMC, The Netherlands
Friday, June 17, 2016:  SESSION 5: Poster Reception  -  5:00pm - 7:00pm